TNFRSF12A and hepatocellular carcinoma: In studies where the LPC response is attenuated by reducing the inflammatory response—especially in transgenic mice with a deficient immune system such as in IL6R, TNFR or FN14 knockout mice—the development of HCC is commensurately reduced [24,26].